BrainsWay Ltd. (BWAY)
9.06
-0.06 (-0.66%)
At close: Apr 25, 2025, 10:15 AM
-0.66% (1D)
| Bid | 9.06 |
| Market Cap | 171.07M |
| Revenue (ttm) | 41.02M |
| Net Income (ttm) | 2.92M |
| EPS (ttm) | 0.18 |
| PE Ratio (ttm) | 50.36 |
| Forward PE | 52.97 |
| Analyst | Buy |
| Ask | 9.25 |
| Volume | 2,267 |
| Avg. Volume (20D) | 59,396 |
| Open | 9.19 |
| Previous Close | 9.12 |
| Day's Range | 8.95 - 9.19 |
| 52-Week Range | 4.72 - 11.79 |
| Beta | 0.16 |
About BWAY
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chro...
Industry Medical - Devices
Sector Healthcare
IPO Date Apr 17, 2019
Employees 120
Stock Exchange NASDAQ
Ticker Symbol BWAY
Website https://www.brainsway.com
Analyst Forecast
According to 3 analyst ratings, the average rating for BWAY stock is "Buy." The 12-month stock price forecast is $12.5, which is an increase of 37.89% from the latest price.
Stock ForecastsNext Earnings Release
BrainsWay Ltd. is scheduled to release its earnings on May 7, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 months ago
+14.5%
BrainsWay shares are trading higher after the comp...
Unlock content with
Pro Subscription
